Vice President of Managed Markets and Specialty Services, Sandoz
Mark is the Vice President of Managed Markets and Specialty Services at Sandoz, a division of Novartis. As part of the Sandoz Biopharma division, his team is fully dedicated to commercializing the organization’s biosimilar portfolio. Prior to joining Sandoz, Mark was the General Manager of Specialty Pharmacy for Cardinal Health. Mark also spent seven years at Genentech, where he led several teams, including Managed Care Marketing, Pricing and Contracting Strategy, Distribution and Channel Strategy and Contracting Operations. Previously, he served in account management, product management and pricing roles at GlaxoSmithKline and AstraZeneca. Mark has an undergraduate degree in finance from Bloomsburg University and an MBA in marketing from Temple University.